"Sentinel Lymph Node" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
First lymph node to receive drainage from the primary tumor. SENTINEL LYMPH NODE BIOPSY is performed to determine early METASTASIS status because cancer cells may appear first in the sentinel node.
| Descriptor ID |
D000071036
|
| MeSH Number(s) |
A10.549.400.750 A15.382.520.604.412.750
|
| Concept/Terms |
Sentinel Lymph Node- Sentinel Lymph Node
- Lymph Node, Sentinel
- Lymph Nodes, Sentinel
- Sentinel Lymph Nodes
- Sentinal Node
- Node, Sentinal
- Nodes, Sentinal
- Sentinal Nodes
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node".
This graph shows the total number of publications written about "Sentinel Lymph Node" by people in this website by year, and whether "Sentinel Lymph Node" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sentinel Lymph Node" by people in Profiles.
-
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites. Immunol Invest. 2021 Jul; 50(5):562-579.
-
Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019 07; 69(4):258-279.
-
Paired-Agent Fluorescence Molecular Imaging of Sentinel Lymph Nodes Using Indocyanine Green as a Control Agent for Antibody-Based Targeted Agents. Contrast Media Mol Imaging. 2019; 2019:7561862.
-
Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates. J Surg Oncol. 2019 Jan; 119(1):101-108.
-
A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2018 May; 25(5):1304-1311.
-
Natural killer cell response is a predictor of good outcome in MCPyV+ Merkel cell carcinoma: A case series of 23 patients. J Am Acad Dermatol. 2017 07; 77(1):31-32.
-
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. Am J Dermatopathol. 2016 Jul; 38(7):499-503.